Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Other financing activities: 2016-2023

Historic Other financing activities for SRx Health Solutions (SRXH) over the last 6 years, with FY2023 value amounting to $1.8 million.

  • SRx Health Solutions' Other financing activities rose 116937.5% to $2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.7 million, marking a year-over-year increase of 25013.09%. This contributed to the annual value of $1.8 million for FY2023, which is 4018.19% down from last year.
  • According to the latest figures from FY2023, SRx Health Solutions' Other financing activities is $1.8 million, which was down 4018.19% from $3.0 million recorded in FY2022.
  • SRx Health Solutions' 5-year Other financing activities high stood at $3.0 million for FY2022, and its period low was $85000.0 during FY2020.
  • For the 5-year period, SRx Health Solutions' Other financing activities averaged around $1.1 million, with its median value being $720000.0 (2019).
  • In the last 5 years, SRx Health Solutions' Other financing activities crashed by 8819.44% in 2020 and then skyrocketed by 202071.43% in 2022.
  • SRx Health Solutions' Other financing activities (Annual) stood at $720000.0 in 2019, then plummeted by 88.19% to $85000.0 in 2020, then surged by 64.71% to $140000.0 in 2021, then skyrocketed by 2020.71% to $3.0 million in 2022, then plummeted by 40.18% to $1.8 million in 2023.
  • Its last three reported values are $1.8 million in FY2023, $3.0 million for FY2022, and $140000.0 during FY2021.